Computed Tomography

Cardiac computed tomography (CT) has become a primary cardiovascular imaging modality in the past 20 years, and was recommended as a 1A recommendation in the 2021 chest pain assessment guidelines. CT calcium scoring has became a primary risk assessment for coronary artery disease and whether patients should be on statins. Coronary CT angiography (CCTA) is used to for anatomical assessment of the arteries for plaque burden and to identify areas of blockage that may cause ischemia and heart attacks. Additional use of contrast CT perfusion or fractional flow reserve CT (FFR-CT) can offer physiological information on the function of the heart. CT plays a primary role in structural heart assessments for heart valves, repair of congenital defects and left atrial appendage occlusion (LAAO) for both pre-procedure planning and procedural guidance. Find more news on general radiology CT use.

Fat attenuation index (FAI) CT imaging of coronary artery fat can show inflammation and can help pin-point vulnerable plaques, or show the reversal of inflammation due to drug therapies. The technology is being developed by the vendor Caristo, which has European CE mark and the company is seeking FDA clearance. #SCCT #SCCT2022

VIDEO: New Technologies in Cardiac CT Imaging

Ron Blankstein, MD, Brigham and Women's Hospital, explains recent advances in coronary computed tomography angiography (CCTA) technology. 

Cardiac CT now in the spotlight thanks to chest pain guidelines

With the elevation of cardiac CT to a 1A indication in the 2021 Chest Pain Guidelines, there has been a large amount of interest in starting coronary artery CT angiography (CCTA) programs. 

VIDEO: 3 challenges for Society of Cardiovascular Computed Tomography members in 2023

Society of Cardiovascular Computed Tomography (SCCT) President Brian Ghoshhajra, MD, detailed three challenges he is making to SCCT members in the coming year. 

How to get paid, reimbursed, for cardiac CT, CTA CCTA. #SCCT #SCCT2022

VIDEO: How imagers get reimbursed for coronary CTA

Ahmad M. Slim, MD, associate professor of medicine with the University of Washington and regional chief medical officer with the Pulse Heart Institute, explained how imagers get paid for coronary computed tomography angiography (CCTA) exams.

Ron Blankstein, MD, MSCCT, associate director, cardiovascular imaging program, director, cardiac computed tomography, Brigham and Women's Hospital, and professor of medicine, Harvard Medical School, was a co-author on the ACC 2021 Chest Pain Guidelines,[1] which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for front line imaging. He gave an overview of the guidelines during the 2022 Society of Cardiovascular CT (SCCT) meeting in July. #SCCT2022

VIDEO: The role of cardiac CT in the 2021 chest pain guidelines

Ron Blankstein, MD, associate director of the cardiovascular imaging program and director of the cardiac computed tomography program for Brigham and Women's Hospital, was a co-author on the ACC 2021 Chest Pain Guidelines, which now lists coronary computed tomography angiography (CCTA or CTA) as a 1A level recommendation for frontline imaging. 

Mitral annular calcium (MAC) does not appear to have a negative effect on long-term transcatheter aortic valve replacement (TAVR) outcomes, according to new research published in the American Journal of Cardiology.

TAVR safe and effective for patients presenting with mitral annular calcium

Researchers from Cleveland Clinic reviewed data from more than 400 patients, presenting their findings in the American Journal of Cardiology.

CT coronary artery calcium (CAC) scoring, also known as the Agatston score, to assess the risk a patient has for future heart attacks and help decide if a patient requires statins.

VIDEO: Current guidelines for the use of CT calcium scoring in preventive cardiology

Mike Shapiro, DO, MD, director of the Center for Prevention of Cardiovascular Disease at Wake Forest University, discusses the current guidelines for computed tomography (CT) calcium scoring as a screening test to assess heart attack risk.

AI cardiology Cleerly soft plaque assessments

Cardiology startup raises $192M for AI-powered imaging assessments

The company has now raised $248M in total to help develop, commercialize and market its FDA-cleared technology.